ATIM-29. A PHASE 1 STUDY OF PF-06840003, AN ORAL INDOLE 2,3-DIOXYGENASE 1 (IDO1) INHIBITOR IN PATIENTS WITH MALIGNANT GLIOMAS
| Image |  |
|---|---|
| Description | scientific article published on 6 November 2017 |
| Author/s |
author: Shilpa Alekar Annick Desjardins Andrew B Lassman Timothy F. Cloughesy |
| Publication date | November 6, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |